CAPS1 Promotes Colorectal Cancer Metastasis Via Snail Mediated Epithelial Mesenchymal Transformation

Guang-Xi Zhao,Ying-Ying Xu,Shu-Qiang Weng,Si Zhang,Ying Chen,Xi-Zhong Shen,Ling Dong,She Chen
DOI: https://doi.org/10.1038/s41388-019-0740-7
IF: 8.756
2019-01-01
Oncogene
Abstract:Colorectal cancer (CRC) is a common gastrointestinal cancer with high mortality rate mostly due to metastasis. Ca 2+ -dependent activator protein for secretion 1 (CAPS1) was originally identified as a soluble factor that reconstitutes Ca 2+ -dependent secretion. In this study, we discovered a novel role of CAPS1 in CRC metastasis. CAPS1 is frequently up-regulated in CRC tissues. Increased CAPS1 expression is associated with frequent metastasis and poor prognosis of CRC patients. Overexpression of CAPS1 promotes CRC cell migration and invasion in vitro, as well as liver metastasis in vivo, without affecting cell proliferation. CAPS1 induces epithelial–mesenchymal transition (EMT), including decreased E-cadherin and ZO-1, epithelial marker expression, and increased N-cadherin and Snail, mesenchymal marker expression. Snail knockdown reversed CAPS1-induced EMT, cell migration and invasion. This result indicates that Snail is required for CAPS1-mediated EMT process and metastasis in CRC. Furthermore, CAPS1 can bind with Septin2 and p85 (subunit of PI3K). LY294002 and wortmanin, PI3K/Akt inhibitors, can abolish CAPS1-induced increase of Akt/GSK3β activity, as well as increase of Snail protein level. Taken together, CAPS1 promotes colorectal cancer metastasis through PI3K/Akt/GSK3β/Snail signal pathway-mediated EMT process.
What problem does this paper attempt to address?